Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
16/07/2026
Citigroup has raised its growth forecast for South Korea's GDP in 2026 from 3.5% to 3.7%.
Latest
2 m ago
Zhi Xiang Golden Ta (688443.SH): Taileqi monoclonal antibody injection adult, severe atopic dermatitis indications for market application accepted for review.
4 m ago
Nobel Prize winner in chemistry Omar Yaghi: China's achievements in the field of artificial intelligence are by no means accidental.
4 m ago
UK Competition and Markets Authority: Letter to private parking lot operators outlining concerns about appeal process and possible unfair additional charges.
5 m ago
Why did Q2 net profit decline compared to the previous quarter? Deming Li's response
5 m ago
Fosun Pharma (02696.HK): The international multicenter Phase 1 clinical study of the biosimilar drug HLX18 (recombinant anti-PD-1 humanized monoclonal antibody injection) developed for various resected solid tumor patients has completed the first global patient dosing in China.
See all latest